Christoph Lengauer - Net Worth and Insider Trading
Christoph Lengauer Net Worth
The estimated net worth of Christoph Lengauer is at least $6 Million dollars as of 2024-06-22. Christoph Lengauer is the Chief Scientific Officer of Blueprint Medicines Corp and owns about 56,657 shares of Blueprint Medicines Corp (BPMC) stock worth over $6 Million. Details can be seen in Christoph Lengauer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christoph Lengauer has not made any transactions after 2016-04-13 and currently still holds the listed stock(s).
Transaction Summary of Christoph Lengauer
Christoph Lengauer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christoph Lengauer owns 2 companies in total, including HOOKIPA Pharma Inc (HOOK) , and Blueprint Medicines Corp (BPMC) .
Click here to see the complete history of Christoph Lengauer’s form 4 insider trades.
Insider Ownership Summary of Christoph Lengauer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HOOK | HOOKIPA Pharma Inc | 2019-04-17 | director |
| BPMC | Blueprint Medicines Corp | 2016-04-13 | Chief Scientific Officer |
Christoph Lengauer Latest Holdings Summary
Christoph Lengauer currently owns a total of 1 stock. Christoph Lengauer owns 56,657 shares of Blueprint Medicines Corp (BPMC) as of April 13, 2016, with a value of $6 Million.
Latest Holdings of Christoph Lengauer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2016-04-13 | 56,657 | 104.23 | 5,905,359 |
Holding Weightings of Christoph Lengauer
Christoph Lengauer Form 4 Trading Tracker
According to the SEC Form 4 filings, Christoph Lengauer has made a total of 0 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years. The most-recent trade in Blueprint Medicines Corp is the sale of 15,872 shares on April 13, 2016, which brought Christoph Lengauer around $317,599.
Insider Trading History of Christoph Lengauer
- 1
Christoph Lengauer Trading Performance
Christoph Lengauer Ownership Network
Christoph Lengauer Owned Company Details
What does HOOKIPA Pharma Inc do?
Who are the key executives at HOOKIPA Pharma Inc?
Christoph Lengauer is the director of HOOKIPA Pharma Inc. Other key executives at HOOKIPA Pharma Inc include director & Chief Financial Officer Reinhard Kandera , director & Chief Executive Officer Jorn Aldag , and Chief Medical Officer Katia Schlienger .
HOOKIPA Pharma Inc (HOOK) Insider Trades Summary
Over the past 18 months, Christoph Lengauer made no insider transaction in HOOKIPA Pharma Inc (HOOK). Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net purchase of 27,000 shares made by Reinhard Kandera , and a net purchase of 20,000 shares made by Jorn Aldag .
In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 47,000 shares were bought by its insiders, resulting in a net purchase of 47,000 shares.
HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
HOOKIPA Pharma Inc Insider Transactions
Christoph Lengauer Mailing Address
Above is the net worth, insider trading, and ownership report for Christoph Lengauer. You might contact Christoph Lengauer via mailing address: Blueprint Medicines Corp., 215 First Street, Suite 340/350, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
